A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Systemic Sclerosis
Clinical trial NCT03798366 · COMPLETED
Trial details
- NCT number
- NCT03798366
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-14
- Primary completion
- 2020-05-21
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.